China National Accord Medicines Corp Ltd (000028) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.020x

Based on the latest financial reports, China National Accord Medicines Corp Ltd (000028) has a cash flow conversion efficiency ratio of -0.020x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-425.23 Million ≈ $-62.23 Million USD) by net assets (CN¥21.55 Billion ≈ $3.15 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 000028 net asset quality score to measure how much of total assets are equity-financed.

China National Accord Medicines Corp Ltd - Cash Flow Conversion Efficiency Trend (1998–2024)

This chart illustrates how China National Accord Medicines Corp Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check China National Accord Medicines Corp Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.

China National Accord Medicines Corp Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of China National Accord Medicines Corp Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Hanall Biopharma
KO:009420
0.047x
Etablissements Maurel et Prom SA
PA:MAU
0.087x
Global Blue Group Holding Ltd
NYSE:GB
0.190x
Republic Bancorp Inc
NASDAQ:RBCAA
0.064x
Grupo Security
SN:SECURITY
0.531x
Suzhou Veichi Electric Co. Ltd. A
SHG:688698
-0.007x
NGL Energy Partners LP
NYSE:NGL
0.309x
Beijing Worldia Diamond Tools Co Ltd
SHG:688028
0.028x

Annual Cash Flow Conversion Efficiency for China National Accord Medicines Corp Ltd (1998–2024)

The table below shows the annual cash flow conversion efficiency of China National Accord Medicines Corp Ltd from 1998 to 2024. For the full company profile with market capitalisation and key ratios, see market value of China National Accord Medicines Corp Ltd.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥20.76 Billion
≈ $3.04 Billion
CN¥3.27 Billion
≈ $478.72 Million
0.158x +12.58%
2023-12-31 CN¥20.98 Billion
≈ $3.07 Billion
CN¥2.94 Billion
≈ $429.80 Million
0.140x +6.33%
2022-12-31 CN¥19.44 Billion
≈ $2.85 Billion
CN¥2.56 Billion
≈ $374.67 Million
0.132x +43.38%
2021-12-31 CN¥18.02 Billion
≈ $2.64 Billion
CN¥1.66 Billion
≈ $242.21 Million
0.092x +3.22%
2020-12-31 CN¥16.89 Billion
≈ $2.47 Billion
CN¥1.50 Billion
≈ $219.90 Million
0.089x -31.68%
2019-12-31 CN¥15.36 Billion
≈ $2.25 Billion
CN¥2.00 Billion
≈ $292.71 Million
0.130x +36.93%
2018-12-31 CN¥13.91 Billion
≈ $2.03 Billion
CN¥1.32 Billion
≈ $193.54 Million
0.095x -26.54%
2017-12-31 CN¥9.93 Billion
≈ $1.45 Billion
CN¥1.29 Billion
≈ $188.08 Million
0.129x -21.63%
2016-12-31 CN¥8.91 Billion
≈ $1.30 Billion
CN¥1.47 Billion
≈ $215.48 Million
0.165x -12.25%
2015-12-31 CN¥5.57 Billion
≈ $814.55 Million
CN¥1.05 Billion
≈ $153.35 Million
0.188x +214.64%
2014-12-31 CN¥4.85 Billion
≈ $709.89 Million
CN¥-796.70 Million
≈ $-116.58 Million
-0.164x -181.81%
2013-12-31 CN¥2.32 Billion
≈ $339.00 Million
CN¥465.03 Million
≈ $68.05 Million
0.201x +13.95%
2012-12-31 CN¥1.84 Billion
≈ $269.11 Million
CN¥323.96 Million
≈ $47.40 Million
0.176x +10.57%
2011-12-31 CN¥1.43 Billion
≈ $208.79 Million
CN¥227.32 Million
≈ $33.26 Million
0.159x -57.90%
2010-12-31 CN¥1.13 Billion
≈ $165.57 Million
CN¥428.16 Million
≈ $62.65 Million
0.378x +22.69%
2009-12-31 CN¥878.13 Million
≈ $128.50 Million
CN¥270.85 Million
≈ $39.63 Million
0.308x -18.77%
2008-12-31 CN¥649.37 Million
≈ $95.02 Million
CN¥246.58 Million
≈ $36.08 Million
0.380x +124.10%
2007-12-31 CN¥517.58 Million
≈ $75.74 Million
CN¥87.70 Million
≈ $12.83 Million
0.169x -55.91%
2006-12-31 CN¥472.90 Million
≈ $69.20 Million
CN¥181.73 Million
≈ $26.59 Million
0.384x +2.04%
2005-12-31 CN¥393.72 Million
≈ $57.61 Million
CN¥148.28 Million
≈ $21.70 Million
0.377x +3.53%
2004-12-31 CN¥358.20 Million
≈ $52.42 Million
CN¥130.30 Million
≈ $19.07 Million
0.364x +53.55%
2003-12-31 CN¥342.86 Million
≈ $50.17 Million
CN¥81.22 Million
≈ $11.89 Million
0.237x +175.64%
2002-12-31 CN¥334.70 Million
≈ $48.98 Million
CN¥28.76 Million
≈ $4.21 Million
0.086x -55.98%
2001-12-31 CN¥364.45 Million
≈ $53.33 Million
CN¥71.16 Million
≈ $10.41 Million
0.195x +828.36%
2000-12-31 CN¥405.06 Million
≈ $59.27 Million
CN¥8.52 Million
≈ $1.25 Million
0.021x -58.36%
1999-12-31 CN¥452.23 Million
≈ $66.18 Million
CN¥22.84 Million
≈ $3.34 Million
0.051x +334.65%
1998-12-31 CN¥448.25 Million
≈ $65.59 Million
CN¥5.21 Million
≈ $762.12K
0.012x --

About China National Accord Medicines Corp Ltd

SHE:000028 China Medical Distribution
Market Cap
$1.49 Billion
CN¥10.20 Billion CNY
Market Cap Rank
#7106 Global
#1485 in China
Share Price
CN¥21.02
Change (1 day)
+0.10%
52-Week Range
CN¥18.91 - CN¥27.00
All Time High
CN¥2829.45
About

China National Accord Medicines Corporation Ltd. engages in the retail and distribution of pharmaceutical products in China and internationally. The company offers prescription drugs for various illnesses and medications requiring long-term use, such as oncology, liver disease, neurology, psychiatry, cardiovascular, and rheumatology/immunology. It also provides traditional Chinese medicine, Weste… Read more